Markets:

Overview

News

Currencies

International

Treasuries

ResMed Inc. Common Stock (NY:RMD)

190.57 -12.85 (-6.32%)

Official Closing Price Updated: 7:00 PM EDT, May 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ResMed Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

19 20 Next >

Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy

December 08, 2025

Technology uses real-world sleep data and machine learning to help people with sleep apnea start and stay on therapy

From Resmed, Inc.

Via GlobeNewswire

ResMed Inc. (NYSE:RMD) Offers a High-Quality Dividend Backed by Strong Fundamentals ↗

December 08, 2025

ResMed (RMD) is a high-quality dividend stock with a secure payout, strong profitability, and a rock-solid balance sheet, ideal for sustainable passive income growth.

Via Chartmill

These S&P500 stocks that are showing activity before the opening bell on Friday. ↗

December 05, 2025

Pre-market stock analysis of S&P500 stocks on 2025-12-05: top gainers and losers in today's session.

Via Chartmill

1 Safe-and-Steady Stock with Competitive Advantages and 2 Facing Headwinds

December 01, 2025

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

Via StockStory

Earnings Scheduled For October 30, 2025 ↗

October 30, 2025

Via Benzinga

Penumbra, Corcept, Elanco, ResMed, and LeMaitre Stocks Trade Up, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut.

Via StockStory

Topics Economy

1 Large-Cap Stock to Target This Week and 2 We Brush Off

November 19, 2025

Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an...

Via StockStory

Discover which S&P500 stocks are making waves on Friday. ↗

November 14, 2025

Stay informed about the performance of the S&P500 index in the middle of the day on Friday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Could GLP-1 Drugs Make ResMed's CPAP Machines Obsolete? ↗

November 12, 2025

ResMed faces an uncertain future as GLP-1 weight loss drugs threaten to reduce demand for sleep apnea devices, creating a complex investment dilemma for shareholders of the CPAP machine leader.

Via The Motley Fool

1 S&P 500 Stock to Research Further and 2 We Turn Down

November 10, 2025

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some...

Via StockStory

Topics Stocks

ResMed Inc. (NYSE:RMD) Offers a Compelling Dividend Profile Supported by Strong Profitability ↗

November 07, 2025

ResMed (RMD) offers a reliable dividend with strong growth potential. Its low payout ratio, high profitability, and financial health support future dividend increases.

Via Chartmill

ResMed’s Q3 Earnings Call: Our Top 5 Analyst Questions

November 06, 2025

ResMed’s third quarter results aligned with Wall Street’s revenue expectations, while its non-GAAP earnings per share moderately outpaced consensus. Management attributed the quarter’s performance to...

Via StockStory

Topics Artificial Intelligence Earnings

Nvidia To Rally Around 73%? Here Are 10 Top Analyst Forecasts For Monday ↗

November 03, 2025

Via Benzinga

In today's session, there are S&P500 stocks with remarkable trading volume. ↗

October 31, 2025

Let's have a look at what is happening on the US markets on Friday. Below you can find the S&P500 stocks with an unusual volume in today's session.

Via Chartmill

Gapping S&P500 stocks in Friday's session ↗

October 31, 2025

Friday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.

Via Chartmill

RMD Q3 Deep Dive: ResMed Launches New Mask Platform and Invests in U.S. Operations

October 31, 2025

Medical device company ResMed (NYSE:RMD) met Wall Streets revenue expectations in Q3 CY2025, with sales up 9.1% year on year to $1.34 billion. Its non-GAAP profit of $2.55 per share was 2.1% above...

Via StockStory

Topics Economy

Nasdaq 100 Rebounds, Amazon Jumps 10% On Strong Earnings: What's Moving Markets Friday? ↗

October 31, 2025

Tech stocks edged higher Friday, rebounding from Thursday's 1.5% drop in the Nasdaq 100 as upbeat earnings from mega-cap giants kept the rally momentum alive.

Via Benzinga

These S&P500 stocks are moving in today's after hours session ↗

October 30, 2025

As the regular session of the US market on Thursday comes to an end, let's delve into the after-hours session and discover the top S&P500 gainers and losers shaping the post-market sentiment.

Via Chartmill

Resmed Inc (NYSE:RMD) Reports Q1 FY2026 Results: Mixed Earnings Beat Fails to Prevent Stock Decline ↗

October 30, 2025

Resmed's Q1 FY2026 earnings met expectations with $1.34B revenue and $2.55 EPS. Despite strong profit growth and margin expansion, the stock traded lower post-announcement.

Via Chartmill

Topics Earnings

ResMed (NYSE:RMD) Reports Q3 In Line With Expectations

October 30, 2025

Medical device company ResMed (NYSE:RMD) met Wall Streets revenue expectations in Q3 CY2025, with sales up 9.1% year on year to $1.34 billion. Its non-GAAP profit of $2.55 per share was 2.1% above...

Via StockStory

Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2026

October 30, 2025

From Resmed, Inc.

Via GlobeNewswire

Insights into ResMed's Upcoming Earnings ↗

October 29, 2025

Via Benzinga

Meta Tumbles 10%, Google Marks Historic Rally: What's Moving Markets Thursday? ↗

October 30, 2025

Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the mega-caps and the lingering impact of hawkish remarks from Fed Chair Jerome...

Via Benzinga

Topics Economy

ResMed (RMD) Reports Q3: Everything You Need To Know Ahead Of Earnings

October 28, 2025

Medical device company ResMed (NYSE:RMD) will be reporting earnings this Thursday afternoon. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence

ResMed Inc (NYSE:RMD) Stands Out as a Quality Investment with Strong Financials ↗

October 28, 2025

ResMed is a top-quality digital health stock with strong revenue growth, high profitability, and excellent cash flow conversion, making it a standout for long-term investors.

Via Chartmill

1 Healthcare Stock to Research Further and 2 We Ignore

October 24, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth. This...

Via StockStory

Topics Stocks

What 9 Analyst Ratings Have To Say About ResMed ↗

October 21, 2025

Via Benzinga

SLB To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

October 21, 2025

Via Benzinga

ResMed Inc. (NYSE:RMD): A Dividend Stock with Strong Profitability and Financial Health ↗

October 17, 2025

ResMed (RMD) is a reliable dividend stock with strong growth, high profitability, and a robust financial condition, ensuring sustainable payouts.

Via Chartmill

October 17, 2025

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can...

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9

...

19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.